Document Detail

Endovascular exclusion of abdominal aortic pathology in patients with concomitant malignancy.
MedLine Citation:
PMID:  11972244     Owner:  NLM     Status:  MEDLINE    
The advent of endoluminal aortic repair has gained increasing popularity as an alternative to traditional open surgery in the setting of multiple comorbid disease states. This study analyzes a single center experience of excluding aortic disease in patients with concomitant malignancy. As part of a Federal Drug Administration FDA-approved trial, 318 patients underwent aortic stent-graft repair between June 1996 and February 2001. During that period five patients with advanced-stage neoplasia were treated. Endovascular management of symptomatic abdominal aortic aneurysms (AAA) with a mean diameter of 7.8 cm (range, 6-10 cm), was performed in four patients. In the fifth patient, a custom-made aortic prosthesis was utilized to exclude a paraanastamotic abdominal aneurysm (PAAA) from a previous open AAA repair. Malignancies included esophageal, lung, renal, prostate, and urinary bladder cancers. A mean follow-up of 10.1 months was available. Successful endoluminal repair was accomplished in all five patients with minimal in-hospital morbidity. Mean length of stay was 3.4 days. There were no device-related mortalities and no persistent endoleaks detected for the duration of follow-up. Aneurysm sac enlargement was not seen in any of the patients and complete resolution of the PAAA was noted at one year. Exclusion of AAA and other aortic pathology in patients with an associated malignancy can be performed with a relatively low procedure-related morbidity and mortality. In this population, stent-graft repair remains an individualized option with a multidisciplinary team necessary to explore this therapeutic approach.
James T Lee; Carlos E Donayre; Irwin Walot; George E Kopchok; Rodney A White
Related Documents :
10390314 - Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal s...
20382494 - Preoperative statin therapy is associated with improved outcomes and resource utilizati...
8866084 - Surgical treatment of infected thoracic and abdominal aortic aneurysms.
19013084 - Endovascular repair of the thoracic aorta: predictors of 30-day mortality in patients o...
21524824 - [measurement of 75se-sehcat abdominal retention in the initial diagnosis of bile acid a...
11921114 - Clinical-pathological study of levodopa complications.
Publication Detail:
Type:  Journal Article; Review     Date:  2002-02-20
Journal Detail:
Title:  Annals of vascular surgery     Volume:  16     ISSN:  0890-5096     ISO Abbreviation:  Ann Vasc Surg     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-04-24     Completed Date:  2002-06-06     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8703941     Medline TA:  Ann Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  150-6     Citation Subset:  IM    
Division of Vascular Surgery, Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Aortic Aneurysm, Abdominal / complications,  mortality,  surgery*
Blood Loss, Surgical
Blood Vessel Prosthesis Implantation / methods*
Follow-Up Studies
Length of Stay
Neoplasms / complications,  pathology
Prosthesis Design
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endovascular repair of a ruptured abdominal aortic and iliac artery aneurysm with an acute iliocaval...
Next Document:  Nonoperative management of acute spontaneous renal artery dissection.